Skip to content

Clinical trials

Phase 2 Glioblastoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: South Korea Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20151
20162
20181
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Bayer1
Clinical Research Center for Solid Tumor, Korea1
Genexine, Inc.1
Incheon St.Mary's Hospital1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Polaris Group1
Samsung Medical Center1
Yong-Kil Hong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma10
Astrocytoma2
Biliary Tract Neoplasms1
Brain Neoplasms1
Colorectal Neoplasms1
Esophageal Squamous Cell Carcinoma1
Granuloma, Plasma Cell1
Hematologic Neoplasms1
Lymphoma, Large-Cell, Anaplastic1
Ovarian Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.